Company Profile

Neurodex Inc
Profile last edited on: 3/5/2020      CAGE: 85YN0      UEI: CK9RG13HMKN5

Business Identifier: Neurological diagnostics: exosome platform providing noninvasive, inexpensive, and robust diagnostic tool.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

38 Park Avenue Extension
Arlington, MA 02474
   (443) 889-8344
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

With the firm's lead indication being Alzheimer's disease - described as a not well understood disease affecting an estimated third of the 65+ age population - NeuroDex develops minimally invasive diagnostics for neurodegenerative disorders with a particular focus on ocusing on developing blood-based diagnostic tests for various neurological conditions. As well as one of a kind services for advancing neurological research and development. NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analysis of these. Envisioning a world where effective and preventative treatments for Alzheimer's exist, principals of the firm note that the pharmaceutical industry has struggled to make headway in the Alzheimer's space due - in somemeasure - to a lack of inexpensive, noninvasive diagnostic tools. The Neurodex effort is to bring the power of exosomes to the neurological diagnostic space - advancingthe firm's technology that has the potential to enable early detection, patient stratification, and disease monitoring. Our proprietary neuron-derived exosome isolation technology can be applied across a number of neurological indications. With our technology, a simple blood draw could allow physicians and researchers to open a window into the brain.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Oded Biran -- CEO, Co-founder

  Erez Eitan -- Chief Scientific Officer

  Christina Mendonca -- Controller

Company News

There are no news available.